Gangliosides influence angiogenesis in an experimental mouse brain tumor

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5392-5397

  Manfredi, Mark G ^a   Lim, Sangmook ^a   Claffey, Kevin P ^b   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; N ACETYLGALACTOSAMINYLTRANSFERASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOSYNTHESIS; BRAIN TUMOR; CELL INTERACTION; CELL MEMBRANE; CONTROLLED STUDY; GENETIC TRANSFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR NECROSIS; VASCULARIZATION;

ANIMALS; BRAIN NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; GANGLIOSIDES; GENE EXPRESSION REGULATION, NEOPLASTIC; LYMPHOKINES; MALE; MICE; MICE, INBRED C57BL; MITOTIC INDEX; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032697563     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.
2. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-I mutant. Nature (bond.), 367: 576-579, 1994.
3. Leon, S. P., Folkerth, R. D., and Black, P. M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer (Phila.), 77:362-372, 1996.
4. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
5. Martin, L., Green, B., Renshaw, C., Lowe, D., Rudland, P., Leinster, S. J., and Winstanley, J. Examining the technique of angiogenesis assessment in invasive breast cancer. Br. J. Cancer, 76: 1046-1054, 1997.
6. Kirsch, M., Strasser, J., Allende, R., Bello, L., Zhang, J., and Black, P. M. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res., 58: 4654-4659, 1998.
7. Cockerill, G. W., Gamble, J. R., and Vadas, M. A. Angiogenesis: models and modulators. Int. Rev. Cytol., 159: 113-160, 1995.
8. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
9. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
10. Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., and Dvorak, A. M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr. Top. Microbiol. Immunol., 237: 97-132, 1999.
11. Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., and Detmar, M. Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc. Natl. Acad. Sci. USA, 94: 13612-13617, 1997.
12. Lewis, C. E., Leek, R., Harris, A., and McGee, J. O. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J. Leukocyte Biol., 57: 747-751, 1995.
13. Ferrara, N. Vascular endothelial growth factor. Eur. J. Cancer, 14: 2413-2422, 1996.
14. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
15. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
16. Cheng, S. Y., Huang, H. J., Nagane, M., Ji, X. D., Wang, D., Shih, C. C., Arap, W., Huang, C. M., and Cavenee, W. K. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor. Proc. Natl. Acad. Sci. USA, 93: 8502-8507, 1996.
17. Brooks, P. C., Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin [see comments]. J. Clin. Invest., 96: 1815-1822, 1995.
18. Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. Definition of two angiogenic pathways by distinct αv integrins. Science (Washington DC), 270: 1500-1502, 1995.
19. Hakomori, S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res., 56: 5309-5318, 1996.
20. Alessandri, G., Cornaglia-Ferraris, P., and Gullino, P. M. Angiogenic and angiostatic microenvironment in tumors-role of gangliosides. Acta Oncol., 36: 383-387, 1997.
21. Chang, F., Li, R., and Ladisch, S. Shedding of gangliosides by human medulloblastoma cells. Exp. Cell Res., 234: 341-346, 1997.
22. Yates, A. J., and Rampersaud, A. Sphingolipids as receptor modulators. An overview. Ann. NY Acad. Sci., 845: 57-71, 1998.
23. Meuillet, E., Cremel, G., Dreyfus, H., and Hicks, D. Differential modulation of basic fibroblast and epidermal growth factor receptor activation by ganglioside GM3 in cultured retinal Muller glia. Glia, 17: 206-216, 1996.
24. Bremer, E. G., Schlessinger, J., and Hakomori, S. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem., 261: 2434-2440, 1986.
25. Zheng, M., Fang, H., Tsuruoka, T., Tsuji, T., Sasaki, T., and Hakomori, S. Regulatory role of GM3 ganglioside in α5β1 integrin receptor for fibronectin-medialed adhesion of FUA169 cells. J. Biol. Chem., 268: 2217-2222, 1993.
26. Fang, L. H., Lucero, M., Kazarian, T., Wei, Q., Luo, F. Y., and Valentino, L. A. Effects of neuroblastoma tumor gangliosides on platelet adhesion to collagen. Clin. Exp. Metastasis, 15: 33-40, 1997.
27. Cheresh, D. A. Structure, function and biological properties of integrin αvβ3 on human melanoma cells. Cancer Metastasis Rev., 10: 3-10, 1991.
28. Ziehe, M., Morbidelli, L., Alessandri, G., and Gullino, P. M. Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Lab. Investig., 67: 711-715, 1992.
29. Alessandri, G., De Cristan, G., Ziehe, M., Cappa, A. P., and Gullino, P. M. Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium. J. Cell. Physiol., 151: 23-28, 1992.
30. Koochekpour, S., Merzak, A., and Pilkington, G. J. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-β isoforms in human glioma cells in vitro. Cancer Lett., 102: 209-215, 1996.
31. Flavin, H. J., Wieraszako, A., and Seyfried, T. N. Enhanced aspartate release from hippocampal slices of epileptic (El) mice. J. Neurochem., 56: 1007-1011, 1991.
32. Seyfried, T. N., Yu, R. K., Saito, M., and Albert, M. Ganglioside composition of an experimental mouse brain tumor. Cancer Res., 47: 3538-3542, 1987.
33. Seyfried, T. N., el-Abbadi, M., and Roy, M. L. Ganglioside distribution in murine neural tumors. Mol. Chem. Neuropathol., 17: 147-167, 1992.
34. Ecsedy, J. A., Manfredi, M. G., Yohe, H. C., and Seyfried, T. N. Ganglioside biosynthetic gene expression in experimental mouse brain tumors. Cancer Res., 57: 1580-1583, 1997.
35. Bai, H., and Seyfried, T. Influence of ganglioside GM3 and high density lipoprotein on the cohesion of mouse brain tumor cells. J. Lipid Res., 38: 160-172, 1997.
36. Folch, J., Lees, M., and Sloane-Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226: 497-509, 1957.
37. Ecsedy, J. A., Yohe, H. C., Bergeron, A. J., and Seyfried, T. N. Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors. J. Lipid Res., 39: 2218-2227, 1998.
38. Seyfried, T. N., El-Abbadi, M., Ecsedy, J. A., Bai, H. W., and Yohe, H. C. Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J. Neurochem., 66: 2026-2033, 1996.
39. Seyfried, T. N., Glaser, G. H., and Yu. R. K. Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures. J. Neurochem., 31: 21-27, 1978.
40. el-Abbadi, M., and Seyfried, T. N. Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol. Chem. Neuropathol., 21: 273-285, 1994.
41. Seyfried, T. N., Novikov, A. M., Irvine, R. A., and Brigande, J. V. Ganglioside biosynthesis in mouse embryos: sialyltransferase IV and the asialo pathway. J. Lipid Res., 35: 993-1001, 1994.
42. Looney, W. B., Mayo, A. A., Allen, P. M., Morrow, J. Y., and Morris, H. P. A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatomata. Br. J. Cancer, 27: 341-344, 1973.
43. Olshefski, R., and Ladisch, S. Intercellular transfer of shed tumor cell gangliosides. FEBS Lett., 386: 11-14, 1996.
44. Li, R., Gage, D., McKallip, R., and Ladisch, S. Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2. Glycoconj. J., 13: 385-389, 1996.
45. Heitger, A., and Ladisch, S. Gangliosides block antigen presentation by human monocytes. Biochim. Biophys. Acta, 1303: 161-168, 1996.
46. Ladisch, S., Li, R., and Olson, E. Ceramide structure predicts tumor ganglioside immunosuppressive activity. Proc. Natl. Acad. Sci. USA, 91: 1974-1978, 1994.
47. Ziche, M., Alessandri, G., and Gullino, P. M. Gangliosides promote the angiogenic response. Lab. Investig., 61: 629-634, 1989.
48. Leek, R. D., Lewis, C. E., Whitehouse, R., Greenall, M., Clarke, J., and Harris, A. L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res., 56: 4625-4629, 1996.
49. Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E. C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., and Seed, B. Tumor induction of VEGF promoter activity in stromal cells. Cell, 94: 715-725, 1998.
50. Orre, M., and Rogers, P. A. Macrophages, and microvessel density in tumors of the ovary. Gynecol. Oncol., 73: 47-50, 1999.
51. Sunderkotter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. Macrophages and angiogenesis. J. Leukocyte Biol., 55: 410-422, 1994.
52. Valentino, L., Moss, T., Olson, E., Wang, H. J., Elashoff, R., and Ladisch, S. Shed tumor gangliosides and progression of human neuroblastoma. Blood, 75: 1564-1567, 1990.
53. Ladisch, S., Kitada, S., and Hays, E. F. Gangliosides shed by tumor cells enhance tumor formation in mice. J. Clin. Investig., 79: 1879-1882, 1987.
54. Li, R. X., and Ladisch, S. Shedding of human neuroblastoma gangliosides. Biochim. Biophys. Acta, 1083: 57-64, 1991.
55. Young, W., Jr., Borgman, C. A., and Wolock, D. M. Modes of shedding of glycosphingolipids from mouse lymphoma cells. J. Biol. Chem., 261: 2279-2283, 1986.
56. Olshefski, R., and Ladisch, S. Synthesis, shedding, and intercellular transfer of human medulloblastoma gangliosides: abrogation by a new inhibitor of glucosylceramide synthase. J. Neurochem., 70: 467-472, 1998.
57. Jennemann, R., Rodden, A., Bauer, B. L., Mennel, H. D., and Wiegandt, H. Glycosphingolipids of human gliomas. Cancer Res., 50: 7444-7449, 1990.
58. Yates, A. J. Glycolipids and gliomas. A review. Neurochem. Pathol., 8: 157-180, 1988.
59. Koochekpour, S., and Pilkington, G. J. Vascular and perivascular GD3 expression in human glioma. Cancer Lett., 104: 97-102, 1996.
60. Nakamura, O., Iwamori, M., Matsutani, M., and Takakura, K. Ganglioside GD3 shedding by human gliomas. Acta Neurochir., 109: 34-36, 1991.
61. Berra, B., Gaini, S. M., and Riboni, L. Correlation between ganglioside distribution and histological grading of human astrocytomas. Int. J. Cancer, 36: 363-366, 1985.
62. Traylor, T. D., and Hogan, E. L. Gangliosides of human cerebral astrocytomas. J. Neurochem., 34: 126-131, 1980.